Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated with Peginterferon Alpha-2a and Ribavirin
NCT01634919 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2024-12-03
Summary
•The purpose of this study is to compare the performance between liver biopsy and non-invasive fibrosis assessments evaluating anti-fibrotic efficacy of peginterferon plus ribavirin in patients with hepatitis C pre- and post-treatment
Conditions
- Chronic Hepatitis C
Interventions
- DEVICE
-
chronic hepatitis C
acoustic radiation force impulse ultrasonography
Sponsors & Collaborators
-
Seoul National University Boramae Hospital
lead OTHER
Principal Investigators
-
Won Kim, Ph.D · SMG-SNU Boramae Medical Center
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2017-02-17
- Completion
- 2018-02-09
Countries
- South Korea
Study Locations
More Related Trials
-
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
NCT00323804 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)
NCT00304551 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C
NCT01754974 ·Status: COMPLETED ·Phase: PHASE3
-
PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
NCT01056172 ·Status: UNKNOWN ·Phase: PHASE4
-
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
NCT00532701 ·Status: COMPLETED ·Phase: PHASE4
-
Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3
NCT00056862 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis C
NCT01596517 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)
NCT00709059 ·Status: COMPLETED
-
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C
NCT00144469 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)
NCT01121705 ·Status: COMPLETED ·Phase: PHASE3
-
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
NCT00630084 ·Status: COMPLETED ·Phase: PHASE4
-
Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
NCT00718172 ·Status: COMPLETED ·Phase: PHASE1
-
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
NCT00154869 ·Status: UNKNOWN ·Phase: PHASE3
-
Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011)
NCT01098097 ·Status: COMPLETED
-
Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4
NCT01884402 ·Status: COMPLETED
-
Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection
NCT02377856 ·Status: COMPLETED ·Phase: PHASE4
-
Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)
NCT00759109 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C
NCT01753557 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336)
NCT00863109 ·Status: COMPLETED
-
Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505)
NCT00724295 ·Status: COMPLETED
-
Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance
NCT01664845 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C
NCT00540345 ·Status: COMPLETED ·Phase: PHASE4
-
Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)
NCT00724373 ·Status: COMPLETED
-
Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
NCT00543244 ·Status: UNKNOWN
-
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4
NCT01686789 ·Status: COMPLETED ·Phase: PHASE4